Evidence map›Paper›PMID 36346631›Full record

ArticleJAMA network open2022

Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon.

Joel Fokom Domgue, Mala Pande, Robert Yu, Florence Manjuh, Edith Welty, Thomas Welty, Laurie Elit, Melissa Lopez-Varon, Jessica Rodriguez, Ellen Baker and 12 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 5 countries.

Joel Fokom DomgueUniversity of Texas MD Anderson Cancer Center, Houston.
Mala PandeUniversity of Texas MD Anderson Cancer Center, Houston.
Robert YuUniversity of Texas MD Anderson Cancer Center, Houston.
Florence ManjuhCameroon Baptist Convention Health Services, Bamenda, Cameroon.
Edith WeltyCameroon Baptist Convention Health Services, Bamenda, Cameroon.
Thomas WeltyCameroon Baptist Convention Health Services, Bamenda, Cameroon.
Laurie ElitCameroon Baptist Convention Health Services, Bamenda, Cameroon.
Melissa Lopez-VaronUniversity of Texas MD Anderson Cancer Center, Houston.
Jessica RodriguezUniversity of Texas MD Anderson Cancer Center, Houston.
Ellen BakerUniversity of Texas MD Anderson Cancer Center, Houston.
Jean-Marie DangouAfrican Regional Office of the World Health Organization, Brazzaville, Congo.
Partha BasuInternational Agency for Research on Cancer of the World Health Organization, Lyon, France.
Marie PlanteDivision of Gynecologic Oncology, CHU de Quebec, Laval University, Quebec, Canada.
Fabrice LecuruInstitut Curie, Paris, France.
Thomas RandallDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Ellen StarrGrounds for Health, Williston, Vermont.
Joseph KamgnoFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Lewis FoxhallUniversity of Texas MD Anderson Cancer Center, Houston.
Alan WaxmanDepartment of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque.
Ernest HawkUniversity of Texas MD Anderson Cancer Center, Houston.
Kathleen SchmelerUniversity of Texas MD Anderson Cancer Center, Houston.
Sanjay SheteUniversity of Texas MD Anderson Cancer Center, Houston.
The University of Texas MD Anderson Cancer Center · USCameroon Baptist Convention Health Services · CMCentre International de Recherche sur le Cancer · FRHarvard Global Health Institute · USInstitut Curie · FRUniversité de Yaoundé I · CMUniversité Laval · CAUniversity of New Mexico · USWorld Health Organization Regional Office for Africa · CG

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672World Health Organization 001
6 · The paper itself

Abstract

Importance: Although Africa has the highest burden of cervical cancer in the world, educational resources to achieve the 90-70-90 targets set by the World Health Organization in its strategy to eliminate cervical cancer are lacking in the region. Objectives: To adapt, implement, and evaluate the Project Extension for Community Health Care Outcomes (ECHO), an innovative learning tool, to build capacity of clinicians to better incorporate new evidence-based guidelines into cervical cancer control policies and clinical practices. Design, Setting, and Participants: This cross-sectional study assessed knowledge and practices of clinicians and support staff regarding cervical cancer prevention and control and compared them among respondents who had attended Project ECHO sessions (prior ECHO attendees) with those who had not but were planning on attending in the near future (newcomers) as part of the Cameroon Cervical Cancer Prevention Project ECHO. Satisfaction of prior ECHO attendees was also evaluated. Data were analyzed from January to March 2022. Main Outcomes and Measures: Main outcomes were practices and knowledge regarding cervical cancer education and prevention and preinvasive management procedures compared among prior ECHO attendees and newcomers. Results: Of the 75 participants (mean [SD] age, 36.4 [10.0] years; 65.7% [95% CI, 54.3%-77.1%] women) enrolled in this study, 41 (54.7%; 95% CI, 43.1%-66.2%) were prior ECHO attendees, and most were clinicians (55 respondents [78.6%; 95% CI, 68.7%-88.4%]). Overall, 50% (95% CI, 37.8%-62.2%) of respondents reported performing cervical cancer screening with visual inspection of the cervix after application of acetic acid (VIA) and/or visual inspection of the cervix after application of Lugol's iodine (VILI), 46.3% (95% CI, 34.0%-58.5%) of respondents reported performing human papillomavirus (HPV) testing, and 30.3% (95% CI, 18.9%-41.7%) of respondents reported performing cervical cytological examination in their practices, Approximately one-fourth of respondents reported performing cryotherapy (25.4% [95% CI, 14.7%-36.1%]), thermal ablation (27.3% [95% CI, 16.2%-38.3%]) or loop electrosurgical excisional procedure (LEEP, 25.0% [95% CI, 14.4%-35.6%]) for treatment of preinvasive disease. The clinical use of many of these screening and treatment tools was significantly higher among prior ECHO attendees compared with newcomers (VIA/VILI: 63.2% [95% CI, 47.4%-78.9%] vs 33.3% [95% CI, 16.0%-50.6%]; P = .03; cryotherapy: 40.5% [95% CI, 24.3%-56.8%] vs 6.7% [95% CI, 0.0%-15.8%]; P = .002; thermal ablation: 43.2% [95% CI, 26.9%-59.6%] vs 6.9% [95% CI, 0.0%-16.4%]; P = .002). Knowledge about cervical cancer education, prevention, and management procedures was satisfactory in 36.1% (95% CI, 23.7%-48.5%) of respondents; this proportion was significantly higher among prior ECHO attendees (53.8% [95% CI, 37.7%-69.9%]) compared with newcomers (4.5% [95% CI, 0.0%-13.5%]; P < .001). Approximately two-thirds of participants (68.8% [95% CI, 51.8%-85.8%]) reported that they had applied knowledge learned in our ECHO sessions to patient care in their practice or adopted best-practice care through their participation in this ECHO program. Conclusions and Relevance: These findings suggest that the Project ECHO e-learning and telementoring program was associated with improved skills for clinicians and support staff and enhanced quality of care for patients. In the COVID-19 era and beyond, reinforced efforts to strengthen cervical cancer knowledge and best practices through distance learning and collaboration are needed.

Indexed as

COVID-19Education, DistanceUterine Cervical NeoplasmsAdultCameroonCross-Sectional StudiesEarly Detection of CancerFemaleHumans

Identifiers

PMID36346631
PMCPMC9644259
OpenAlexW4308517758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.